Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
Expert Opinion on Drug Safety|February 26, 2025
Post-marketing safety of Adagrasib: a disproportionality analysis based on the FAERS databaseZheng Shi, Xiayao Yu, Yifan Zhao, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 24, 2021
Liquid chromatography-mass spectrometry based metabolic characterization of pleural effusion in patients with acquired EGFR-TKI resistanceNa Li, Weimin Mao, Yun Gao, et al.
Acta Biochimica Et Biophysica Sinica|August 8, 2014
Everolimus and zoledronic acid--a potential synergistic treatment for lung adenocarcinoma bone metastasisYongfeng Yu, Zhengbo Song, Shunfang Yang, et al.
Therapeutic Advances in Medical Oncology|May 13, 2024
Assessment of efficacy and safety of MET tyrosine kinase inhibitors in non-small-cell lung cancer patients with MET alterationsYanhua Wang, Manyi Xu, Ke Wang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 16, 2024
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterationsYanhua Wang, Jingwen Wei, Manyi Xu, et al.
Journal of Cancer Research and Clinical Oncology|April 25, 2012
EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinomaYongfeng Yu, Zhengbo Song, Hui Gao, et al.
Pageof 20